thyroid cancer, poorly differentiated
Showing 1 - 25 of >10,000
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T
Recruiting
- Anaplastic Thyroid Cancer
- Relapsed/Refractory Poorly Differentiated Thyroid Cancer
- AIC100 CAR T Cells
-
New York, New YorkWeill Cornell Medical College
Feb 14, 2022
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)
Active, not recruiting
- Differentiated Thyroid Cancer (DTC)
- Poorly Differentiated Thyroid Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8
Suspended
- Metastatic Thyroid Gland Carcinoma
- +2 more
- Lenvatinib
- +2 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021
Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)
Recruiting
- Differentiated Thyroid Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 9, 2023
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride
Not yet recruiting
- Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
- Anlotinib Hydrochloride Capsule and Penpulimab
-
Beijing, Beijing, ChinaYansongLin
Sep 25, 2023
Quality of Life in Differentiated Thyroid Carcinoma Undergoing
Not yet recruiting
- Thyroid Cancer
- minimally invasive procedure
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hopsital
Sep 13, 2023
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Efficacy of Lenvatinib in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Cancer
- Gender
-
Rome, ItalyRegina Elena National Cancer Institute
Mar 16, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Differentiated Thyroid Cancer Trial in China (AL2846 capsule)
Recruiting
- Differentiated Thyroid Cancer
- AL2846 capsule
-
Guilin, Guangxi, China
- +3 more
Feb 27, 2023
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,
Recruiting
- Thyroid Cancer
- Thyrogen
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Locally Advanced or Metastatic Radioiodine-Refractory
Recruiting
- Thyroid Neoplasms
- Anlotinib Hydrochloride Capsule
-
Beijing, Beijing, China
- +2 more
Aug 9, 2023
Differentiated Thyroid Cancer Trial in Beijing (Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive
Recruiting
- Differentiated Thyroid Cancer
- Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
- radioactive iodine
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 28, 2022
Renal Tracer Elimination in Thyroid Cancer Patients Treated With
Completed
- Thyroid Carcinoma
-
Jena, Thüringen, GermanyUniversity Hospital Jena
Dec 15, 2022
Differentiated Thyroid Cancer Trial (Low iodine diet)
Not yet recruiting
- Differentiated Thyroid Cancer
- Low iodine diet
- (no location specified)
Oct 25, 2022